-
Bleeding risks for oral anticoagulants and aspirin mostly similar
Rates of major bleeding and intracranial hemorrhage are similar for apixaban and dabigatran versus aspirin, while rates are higher for... Read more -
Drug may counteract muscle loss and osteoporosis after rapid weight loss
Weight-loss medication has taken the world by storm and helped many overweight people. But for some, significant weight loss also... Read more -
Why anti-TNF drugs don't work for some kids with Crohn's disease
A study by Michigan Medicine researchers has investigated possible genetic factors for drug efficacy for children with Crohn's disease.... Read more -
Common antibiotic could treat inflammatory bowel disease, new study finds
An antibiotic used to treat infective diarrhea could be an effective drug for a type of inflammatory bowel disease, a... Read more -
Opioid prescriptions in the ED linked to small increases in future opioid use, hospitalizations
Opioid prescriptions in the emergency department (ED) were associated with small increases in later opioid prescriptions and hospital admissions, found... Read more -
What is botulism? How this 'nerve-paralyzing illness' can be linked to dodgy botox
The news last week that three people in Sydney were hospitalized with botulism after receiving botox injections has raised questions... Read more -
Dietary supplement shown to restore cardiac function
A dietary supplement developed at the Baker Heart and Diabetes Institute has been found to stop the progression of heart... Read more -
Researchers call for regulations to enhance safety of medicines through e-pharmacies in India and Kenya
Researchers from The George Institute for Global Health, with collaborators from Strathmore Business School in Kenya and the London School... Read more -
Bad in small doses—how misuse of antibiotics contributes to bacterial drug resistance
Evidence has emerged about the way bacteria become resistant to multiple drugs. The findings by a John Innes Centre research... Read more -
New 'all-tablet' treatment shows promise for common form of leukemia
An international study published in the New England Journal of Medicine provides hope for chronic lymphocytic leukemia (CLL) patients with... Read more -
Updated drug information handout outdoes FDA's version in clinical trial
A clinical trial comparing a one-page medication handout proposed by the U.S. Food and Drug Administration (FDA) with an updated... Read more -
FDA approves Symbravo for acute treatment of migraine in adults
The U.S. Food and Drug Administration has approved Axsome Therapeutics' Symbravo (meloxicam and rizatriptan) for the acute treatment of migraine... Read more -
AI tool helps find life-saving medicine for rare disease
After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a patient... Read more -
Opioid delta-receptor agonists alleviate stress-induced irritable bowel syndrome symptoms in mouse model
Irritable bowel syndrome (IBS) is a common digestive disorder that affects the intestine, causing symptoms such as abdominal pain, bloating,... Read more -
Drug reverses groin hernias in male mice without surgery, shows promise in humans
By age 75, a noteworthy 50% of men develop an inguinal (groin) hernia—a bulge that results from soft tissue pushing... Read more
